🇺🇸 FDA
Patent

US 9920033

Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

granted A61KA61K31/436A61K31/4709

Quick answer

US patent 9920033 (Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/436, A61K31/4709, A61K38/21, A61K45/06